[
フレーム ]
Please make JavaScript on and see this site.
Menu of each service Menu for each of you Menu of each product type
Back
Regulations & Services of PMDA
Information about Approved Products in Japan
Information for approved products in Japan
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
Regulations and services of PMDA
Information for approved products in Japan
Back
Regulations and Services of PMDA
Information for apporoved products in Japan
Regulations and Services of PMDA
Information for apporoved products in Japan
Reviews and Related Services
Post-marketing Safety Measures
Reviews and Related Services
Post-marketing Safety Measures
Regulatory Science/The Science Board/Standard Development
The 1st Subcommittee on AI (Artificial Intelligence)
Press Releaseopen close
Date and Time: January 13, 2017 from 10am to 12pm
Agenda / List of Handouts
Agenda
Lectures and Exchange of Opinions About Subcommittee 3 (AI:Artificial Intelligence)
Utilization of New Elements Different From Conventional Technology to Medical Devices
Recent Activities of the Science Board Subcommittees
Subcommittee 1 (Rare Cancers)
Subcommittee 2 (Pharmaceutical Development)
List of Handouts
Document 1 Subcommittee 3 (AI:Artificial Intelligence) Scope
Document 2 Dr. Matsuo Lecture Explanatory Material
Document 3 Dr. Suda Lecture Explanatory Material
Document 4 Recent Activities of the Science Board Subcommittee
Document 5 Addition of a New Member to the Subcommittee 2 (Pharmaceutical Development)(Draft)
Copyright © Pharmaceuticals and Medical Devices Agency, All Rights Reserved.